株式会社極東書店トップ > 商品一覧 > Nanovaccines: An Innovative Technology to Fight Human and Animal Diseases. 2019 ed.
商品詳細
Nanovaccines: An Innovative Technology to Fight Human and Animal Diseases. 2019 ed.
・ISBN 978-3-030-31667-9 hard EUR 99.99
¥26,726.- (税込) ※(※)価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | Rosales-Mendoza, Sergio / Gonzalez-Ortega, Omar, |
|---|---|
| 出版社 | (Springer Nature Switzerland AG, SZ) |
| 出版年月 | 2019 |
| ページ数 | 343 pp. |
| 言語 | ENG |
| ニュース番号 | <A02-56534> |
解説
This book provides a compilation of the current developments in mucosal nanovaccines, which are an attractive approach to fight against infectious and non-communicable diseases. Since nanomaterials possess unique properties; many of them have a positive effect on vaccine efficacy when used as antigen carriers and have been applied in vaccinology with significant advances over the past years. This book addresses the methodologies for mucosal nanovaccines synthesis; based on the following nanomaterials: gold, PLGA, silica, and chitosan nanoparticles; as well as nanogels, carbon nanotubes, liposomes, and Virus-like particles. A description of the immunogenic properties of the mucosal nanovaccines is presented, highlighting the improvements achieved with this approach when compared to conventional formulations. Mucosal vaccines constitute the most practical immunization approach since they are easy to administer (promoting patient?s comfort and increasing compliance), allow triggering relevant immune responses at both the site of administration and distant compartments, and thus may protect the main entry portal for pathogens (oral, nasal, and genital mucosae). In this context, the potential of nanovaccines to result in new mucosal formulations in the benefit of global health is analyzed.
- Covers the synthesis and functionalization of nanomaterials for the development of nanovaccines;
- Discusses the underlying mechanisms involved in the induction of immune responses through mucosal compartments and the advantages of nanomaterials in the formulation of nanovaccines;
- Transmits the state of the art for the development of mucosal nanovaccines;
- Provides routes for the design and evaluation of mucosal nanovaccines;
- Presents key perspectives for the field of mucosal vaccine development.